Chemed Corp (CHE) - Net Assets
Based on the latest financial reports, Chemed Corp (CHE) has net assets worth $1.08 Billion USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.62 Billion) and total liabilities ($546.94 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Chemed Corp asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.08 Billion |
| % of Total Assets | 66.31% |
| Annual Growth Rate | 6.66% |
| 5-Year Change | 24.17% |
| 10-Year Change | 118.02% |
| Growth Volatility | 18.12 |
Chemed Corp - Net Assets Trend (1985–2024)
This chart illustrates how Chemed Corp's net assets have evolved over time, based on quarterly financial data. Also explore CHE total assets for the complete picture of this company's asset base.
Annual Net Assets for Chemed Corp (1985–2024)
The table below shows the annual net assets of Chemed Corp from 1985 to 2024. For live valuation and market cap data, see CHE market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.12 Billion | +1.00% |
| 2023-12-31 | $1.11 Billion | +38.71% |
| 2022-12-31 | $798.72 Million | +28.15% |
| 2021-12-31 | $623.27 Million | -30.84% |
| 2020-12-31 | $901.20 Million | +24.03% |
| 2019-12-31 | $726.61 Million | +22.88% |
| 2018-12-31 | $591.33 Million | +9.43% |
| 2017-12-31 | $540.35 Million | +3.10% |
| 2016-12-31 | $524.10 Million | +2.11% |
| 2015-12-31 | $513.25 Million | +13.71% |
| 2014-12-31 | $451.36 Million | +0.55% |
| 2013-12-31 | $448.89 Million | -0.97% |
| 2012-12-31 | $453.29 Million | +9.57% |
| 2011-12-31 | $413.68 Million | -10.47% |
| 2010-12-31 | $462.05 Million | -3.17% |
| 2009-12-31 | $477.16 Million | +28.41% |
| 2008-12-31 | $371.59 Million | +1.99% |
| 2007-12-31 | $364.35 Million | -13.53% |
| 2006-12-31 | $421.36 Million | +9.68% |
| 2005-12-31 | $384.18 Million | +15.68% |
| 2004-12-31 | $332.09 Million | +72.34% |
| 2003-12-31 | $192.69 Million | -5.21% |
| 2002-12-31 | $203.28 Million | -8.65% |
| 2001-12-31 | $222.52 Million | -2.58% |
| 2000-12-31 | $228.41 Million | +7.74% |
| 1999-12-31 | $212.00 Million | -5.10% |
| 1998-12-31 | $223.40 Million | -2.06% |
| 1997-12-31 | $228.10 Million | -0.26% |
| 1996-12-31 | $228.70 Million | -8.41% |
| 1995-12-31 | $249.70 Million | +12.22% |
| 1994-12-31 | $222.50 Million | +31.50% |
| 1993-12-31 | $169.20 Million | +4.32% |
| 1992-12-31 | $162.20 Million | -1.93% |
| 1991-12-31 | $165.40 Million | +21.35% |
| 1990-12-31 | $136.30 Million | -6.06% |
| 1989-12-31 | $145.10 Million | +30.49% |
| 1988-12-31 | $111.20 Million | -1.77% |
| 1987-12-31 | $113.20 Million | -5.51% |
| 1986-12-31 | $119.80 Million | +32.38% |
| 1985-12-31 | $90.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Chemed Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9318.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.72 Billion | 243.24% |
| Common Stock | $37.42 Million | 3.34% |
| Other Comprehensive Income | $2.22 Million | 0.20% |
| Total Equity | $1.12 Billion | 100.00% |
Chemed Corp Competitors by Market Cap
The table below lists competitors of Chemed Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Immunitybio Inc
NASDAQ:IBRX
|
$5.96 Billion |
|
Hangzhou Tigermed Consulting
SHE:300347
|
$5.96 Billion |
|
Sulzer AG
SW:SUN
|
$5.96 Billion |
|
Grupo Financiero Galicia S.A.
BA:GGAL
|
$5.96 Billion |
|
Bank Millennium S.A.
WAR:MIL
|
$5.95 Billion |
|
Definity Financial Corp
TO:DFY
|
$5.95 Billion |
|
Chongyi Zhangyuan Tungsten Co Ltd
SHE:002378
|
$5.95 Billion |
|
SIAM CEMENT UNSP.ADS/1
F:TCM
|
$5.95 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chemed Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,107,876,000 to 1,118,993,000, a change of 11,117,000 (1.0%).
- Net income of 301,999,000 contributed positively to equity growth.
- Dividend payments of 27,092,000 reduced retained earnings.
- Share repurchases of 361,389,000 reduced equity.
- Other comprehensive income increased equity by 140,999.
- Other factors increased equity by 97,458,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $302.00 Million | +26.99% |
| Dividends Paid | $27.09 Million | -2.42% |
| Share Repurchases | $361.39 Million | -32.3% |
| Other Comprehensive Income | $141.00K | +0.01% |
| Other Changes | $97.46 Million | +8.71% |
| Total Change | $- | 1.00% |
Book Value vs Market Value Analysis
This analysis compares Chemed Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.73x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 90.01x to 5.73x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $4.69 | $422.16 | x |
| 1986-12-31 | $5.86 | $422.16 | x |
| 1987-12-31 | $5.97 | $422.16 | x |
| 1988-12-31 | $5.76 | $422.16 | x |
| 1989-12-31 | $5.86 | $422.16 | x |
| 1990-12-31 | $5.42 | $422.16 | x |
| 1991-12-31 | $6.94 | $422.16 | x |
| 1992-12-31 | $6.80 | $422.16 | x |
| 1993-12-31 | $7.00 | $422.16 | x |
| 1994-12-31 | $9.45 | $422.16 | x |
| 1995-12-31 | $10.58 | $422.16 | x |
| 1996-12-31 | $11.00 | $422.16 | x |
| 1997-12-31 | $11.39 | $422.16 | x |
| 1998-12-31 | $11.06 | $422.16 | x |
| 1999-12-31 | $10.08 | $422.16 | x |
| 2000-12-31 | $11.50 | $422.16 | x |
| 2001-12-31 | $11.45 | $422.16 | x |
| 2002-12-31 | $10.28 | $422.16 | x |
| 2003-12-31 | $9.68 | $422.16 | x |
| 2004-12-31 | $13.48 | $422.16 | x |
| 2005-12-31 | $14.61 | $422.16 | x |
| 2006-12-31 | $15.80 | $422.16 | x |
| 2007-12-31 | $14.53 | $422.16 | x |
| 2008-12-31 | $15.90 | $422.16 | x |
| 2009-12-31 | $20.98 | $422.16 | x |
| 2010-12-31 | $20.06 | $422.16 | x |
| 2011-12-31 | $19.75 | $422.16 | x |
| 2012-12-31 | $23.44 | $422.16 | x |
| 2013-12-31 | $24.15 | $422.16 | x |
| 2014-12-31 | $25.30 | $422.16 | x |
| 2015-12-31 | $29.46 | $422.16 | x |
| 2016-12-31 | $31.22 | $422.16 | x |
| 2017-12-31 | $32.28 | $422.16 | x |
| 2018-12-31 | $35.19 | $422.16 | x |
| 2019-12-31 | $43.96 | $422.16 | x |
| 2020-12-31 | $54.96 | $422.16 | x |
| 2021-12-31 | $39.11 | $422.16 | x |
| 2022-12-31 | $52.90 | $422.16 | x |
| 2023-12-31 | $72.89 | $422.16 | x |
| 2024-12-31 | $73.69 | $422.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chemed Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.99%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.42%
- • Asset Turnover: 1.46x
- • Equity Multiplier: 1.49x
- Recent ROE (26.99%) is above the historical average (18.54%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 24.20% | 5.88% | 1.62x | 2.54x | $12.85 Million |
| 1986 | 30.72% | 10.24% | 1.31x | 2.29x | $24.82 Million |
| 1987 | 18.02% | 5.22% | 1.48x | 2.33x | $9.08 Million |
| 1988 | 19.69% | 4.37% | 1.55x | 2.90x | $10.78 Million |
| 1989 | 21.69% | 4.43% | 1.76x | 2.78x | $14.12 Million |
| 1990 | 14.76% | 2.77% | 1.83x | 2.91x | $5.35 Million |
| 1991 | 37.95% | 15.02% | 0.97x | 2.61x | $38.96 Million |
| 1992 | 11.76% | 3.92% | 0.99x | 3.03x | $2.35 Million |
| 1993 | 14.21% | 3.71% | 1.22x | 3.14x | $5.78 Million |
| 1994 | 23.56% | 6.81% | 1.28x | 2.71x | $25.27 Million |
| 1995 | 11.07% | 3.30% | 1.31x | 2.55x | $2.23 Million |
| 1996 | 14.82% | 4.72% | 1.22x | 2.57x | $10.51 Million |
| 1997 | 13.28% | 8.87% | 0.76x | 1.97x | $7.49 Million |
| 1998 | 8.91% | 5.22% | 0.89x | 1.92x | $-2.44 Million |
| 1999 | 9.29% | 4.34% | 1.08x | 1.99x | $-1.50 Million |
| 2000 | 9.01% | 4.11% | 1.19x | 1.84x | $-2.26 Million |
| 2001 | -4.66% | -2.17% | 1.20x | 1.78x | $-32.63 Million |
| 2002 | -0.89% | -0.58% | 0.93x | 1.67x | $-22.14 Million |
| 2003 | -1.78% | -1.11% | 0.94x | 1.71x | $-22.70 Million |
| 2004 | 8.28% | 3.74% | 0.89x | 2.49x | $-5.70 Million |
| 2005 | 9.32% | 3.87% | 1.11x | 2.17x | $-2.60 Million |
| 2006 | 12.02% | 4.97% | 1.28x | 1.88x | $8.51 Million |
| 2007 | 17.56% | 5.82% | 1.42x | 2.12x | $27.54 Million |
| 2008 | 19.11% | 6.18% | 1.51x | 2.05x | $33.86 Million |
| 2009 | 15.46% | 6.20% | 1.45x | 1.72x | $26.07 Million |
| 2010 | 17.71% | 6.39% | 1.54x | 1.80x | $35.63 Million |
| 2011 | 20.78% | 6.34% | 1.70x | 1.92x | $44.61 Million |
| 2012 | 19.70% | 6.24% | 1.66x | 1.90x | $43.97 Million |
| 2013 | 17.20% | 5.46% | 1.58x | 1.99x | $32.34 Million |
| 2014 | 22.00% | 6.82% | 1.69x | 1.91x | $54.18 Million |
| 2015 | 21.49% | 7.14% | 1.81x | 1.66x | $58.95 Million |
| 2016 | 20.75% | 6.90% | 1.79x | 1.68x | $56.33 Million |
| 2017 | 18.17% | 5.89% | 1.81x | 1.70x | $44.14 Million |
| 2018 | 34.76% | 11.53% | 1.83x | 1.65x | $146.41 Million |
| 2019 | 30.27% | 11.34% | 1.53x | 1.75x | $147.26 Million |
| 2020 | 35.45% | 15.36% | 1.45x | 1.59x | $229.35 Million |
| 2021 | 43.09% | 12.55% | 1.59x | 2.15x | $206.22 Million |
| 2022 | 31.25% | 11.69% | 1.48x | 1.81x | $169.75 Million |
| 2023 | 24.60% | 12.03% | 1.36x | 1.51x | $161.72 Million |
| 2024 | 26.99% | 12.42% | 1.46x | 1.49x | $190.10 Million |
Industry Comparison
This section compares Chemed Corp's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $87,960,861
- Average return on equity (ROE) among peers: 7.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chemed Corp (CHE) | $1.08 Billion | 24.20% | 0.51x | $5.96 Billion |
| Acadia Healthcare Company Inc (ACHC) | $25.11 Million | 24.73% | 0.81x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $34.55 Million | 0.57% | 2.43x | $1.84 Billion |
| agilon health Inc (AGL) | $-284.73 Million | 0.00% | 0.00x | $264.44 Million |
| Airsculpt Technologies Inc (AIRS) | $83.53 Million | 12.63% | 1.40x | $136.11 Million |
| Amedisys Inc (AMED) | $364.01 Million | 10.51% | 0.27x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $182.11 Million | 9.41% | 1.84x | $624.22 Million |
| American Shared Hospital Service (AMS) | $17.06 Million | 8.10% | 1.71x | $11.17 Million |
| American Oncology Network Inc. (AONC) | $62.02 Million | 4.17% | 4.26x | $270.55 Million |
| Ardent Health Partners, Inc. (ARDT) | $396.01 Million | 3.69% | 1.74x | $1.29 Billion |
| Astrana Health Inc (ASTH) | $-46.39K | 0.00% | 0.00x | $1.57 Billion |
About Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commer… Read more